NF-2’s First Clinical Trial in Patients!

EXCITING NEWS,  University of Florida, NF clinic is excited to be the site for NF-2’s first clinical trial in patients suffering from progressive meningiomas seen in NF-2 patients.
If you are a patient, you are an adult or adolescent (12 years of age or older) and have a disease called Neurofibromatosis Type 2 (NF2) you may be eligible to participate in a study to investigate the safety and efficacy of an investigational drug called REC-2282. About 90 participants will take part in this study.
Please contact Hans Shuhaiber at 
NF2 Poster